ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 093,52
0,50%
DAX
17 896,50
-0,14%
Brent Oil
83,075
-0,56%
Bitcoin
59 194,00
1,64%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioMarin Pharmaceutical Inc (BMRN)

  7. BioMarin Pharmaceutical Inc (BMRN) Actualités

BMRN BioMarin Pharmaceutical Inc

84,375
1,05 (1,25%)
Dernière mise à jour : 17:38:54
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BioMarin Pharmaceutical Inc BMRN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,05 1,25% 84,375 17:38:54
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
82,91 81,43 84,375 83,33
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202422:03PRNUSBioMarin Reports Record Financial Results for the First..
10/4/202414:00PRNUSBioMarin to Host First Quarter 2024 Financial Results..
12/3/202413:30PRNUSNew Data to be Presented for BioMarin's VOXZOGO®..
08/3/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:30PRNUSBioMarin Announces Appointment of Cristin Hubbard as Chief..
06/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:17EDGAR2Form 144 - Report of proposed sale of securities
05/3/202420:41EDGAR2Form 144 - Report of proposed sale of securities
05/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:00PRNUSBioMarin Scheduled to Participate in March Investor..
29/2/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202419:34EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:06EDGAR2Form 8-K - Current report
22/2/202422:03PRNUSBioMarin Reports Record Financial Results for the Fourth..
12/2/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202421:24EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
12/2/202421:04EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
09/2/202423:46EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202416:36EDGAR2Form 144 - Report of proposed sale of securities
08/2/202415:46EDGAR2Form 144 - Report of proposed sale of securities
08/2/202414:00PRNUSBioMarin to Host Fourth Quarter and Full-Year 2023 Financial..
06/2/202414:30PRNUSBioMarin to Present ROCTAVIAN™ (valoctocogene..
26/1/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:06EDGAR2Form 8-K - Current report
11/1/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202416:09EDGAR2Form 144 - Report of proposed sale of securities
09/1/202417:48EDGAR2Form 144 - Report of proposed sale of securities
03/1/202414:00PRNUSBioMarin to Present at the 42nd Annual J.P. Morgan..
28/12/202319:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202319:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/12/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202319:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/12/202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202319:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/12/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:57EDGAR2Form 144 - Report of proposed sale of securities
20/12/202323:22EDGAR2Form 8-K - Current report
20/12/202322:05PRNUSBioMarin Announces Governance Enhancements and Value..
15/12/202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202317:49EDGAR2Form 144 - Report of proposed sale of securities
13/12/202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
BMRN
BioMarin Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés